Evidence map›Paper›PMID 42714178›Full record

ReviewChemical reviews2026

Milestones in the Elucidation of Heme Biosynthesis.

Harry A Dailey

Abstract readReview
In one paragraph

Review in Chemical reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Harry A DaileyDepartment of Microbiology, Department of Biochemistry & Molecular Biology, University of Georgia, Athens, Georgia30602, United States.ORCID 0009-0008-7161-5930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heme (protoheme IX) is an essential cofactor in biology, serving diverse roles including, but not limited to, one-electron reactions, oxygen transport, catalysis, and signaling. The elucidation of its biosynthetic pathway represents one of the more remarkable scientific accomplishments of the past century. Early 19th-century chemists first isolated, named and characterized porphyrins, while their structural determination by Fischer in the 1920s earned a Nobel Prize. The mid-20th century ushered in isotopic tracer studies which revealed glycine and succinyl-CoA as the starting substrates for the pathway to heme. Identification of porphobilinogen (PBG) as an early pathway intermediate led to the identification of 5-aminolevulinic acid (ALA) as the first committed pathway precursor. Subsequent decades brought the recognition of porphyrinogens as true pathway intermediates, the sequence of decarboxylation and oxidation steps, the identification of the glutamate-based pathway to ALA in plants and most bacteria, the characterization of all pathway enzymes, the discovery of alternate bacterial pathways, and identification of multiprotein complexes. This review traces the historical progression of discoveries, highlighting both the breakthroughs and missteps that shape the current view of heme biosynthesis, and underscores the interplay of chemistry, physiology, and molecular biology in unraveling this ancient metabolic pathway.

Indexed as

HemeBacteriaHistory, 20th CenturyHumansHeme

Identifiers

PMID42714178
PMCPMC13564367

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.